{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:28:08Z","timestamp":1791070088456,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":4479,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1111\/j.1600-6143.2010.03224.x","type":"journal-article","created":{"date-parts":[[2010,9,10]],"date-time":"2010-09-10T03:58:53Z","timestamp":1284091133000},"page":"2017-2025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Biopsy\u2010Diagnosed Renal Disease in Patients After Transplantation of Other Organs and Tissues"],"prefix":"10.1016","volume":"10","author":[{"given":"A.","family":"Schwarz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Haller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Koenecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Strassburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Lehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.U","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Broecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2010.03224.x_bib1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM200003023420901","article-title":"Improved graft survival after renal transplantation in the United States, 1988 to 1996","volume":"342","author":"Hariharan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib2","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy","volume":"349","author":"Nankivell","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1523-1755.2005.00087.x","article-title":"Risk factors for chronic allograft nephropathy after renal transplantation: A protocol biopsy study","volume":"67","author":"Schwarz","year":"2005","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib4","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/00007890-199703150-00009","article-title":"Cyclosporine\u2010associated end\u2010stage nephropathy after cardiac transplantation: Incidence and progression","volume":"63","author":"Goldstein","year":"1997","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib5","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1681\/ASN.V1051136","article-title":"Renal failure in the recipients of nonrenal solid organ transplants","volume":"10","author":"Wilkinson","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib6","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib7","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/j.1523-1755.2005.00558.x","article-title":"Posttransplantation chronic renal damage in nonrenal transplant recipients","volume":"68","author":"Stratta","year":"2005","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib8","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1681\/ASN.2007040394","article-title":"Chronic kidney disease after nonrenal solid\u2010organ transplantation","volume":"18","author":"Bloom","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM198409133111103","article-title":"Cyclosporine\u2010associated chronic nephropathy","volume":"311","author":"Myers","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib10","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/00007890-199010000-00012","article-title":"Cyclosporine nephrotoxicity in cardiac allograft patients\u2014a seven\u2010year follow\u2010up","volume":"50","author":"Greenberg","year":"1990","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1399-0012.1995.tb00305.x","article-title":"Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients","volume":"9","author":"Kuo","year":"1995","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib12","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00007890-199211000-00021","article-title":"Cyclosporine nephrotoxicity in lung transplant recipients","volume":"54","author":"Zaltzman","year":"1992","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000168677","article-title":"Time course of the decline in renal function in cyclosporine\u2010treated heart transplant recipients","volume":"14","author":"Zietse","year":"1994","journal-title":"Am J Nephrol"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00007890-199807150-00010","article-title":"Chronic renal failure following liver transplantation: A retrospective analysis","volume":"66","author":"Fisher","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000045534","article-title":"Risk factors for chronic renal dysfunction in cardiac allograft recipients","volume":"84","author":"Esposito","year":"2000","journal-title":"Nephron"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib16","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1053\/jlts.2003.50113","article-title":"Independent risk factors and natural history of renal dysfunction in liver transplant recipients","volume":"9","author":"Pawarode","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib17","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.healun.2003.08.025","article-title":"Hypertension as a marker for later development of end\u2010stage renal failure after lung and heart\u2010lung transplantation: A cohort study","volume":"23","author":"Kunst","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib18","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1097\/01.TP.0000137176.95730.5B","article-title":"Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation","volume":"78","author":"Sanchez","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib19","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/j.1600-6143.2005.00930.x","article-title":"Progressive chronic kidney disease after pediatric lung transplantation","volume":"5","author":"Hmiel","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib20","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.healun.2007.08.006","article-title":"Dialysis after lung transplantation: Prevalence, risk factors and outcome","volume":"26","author":"Mason","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib21","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/ndt\/16.8.1681","article-title":"Outcome in patients with end\u2010stage renal disease following heart or heart\u2013lung transplantation receiving peritoneal dialysis","volume":"16","author":"Jayasena","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1600-6143.2006.01640.x","article-title":"The outcome of heart transplant recipients following the development of end\u2010stage renal disease: Analysis of the Canadian Organ Replacement Register (CORR)","volume":"7","author":"Alam","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib23","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/ndt\/gfl811","article-title":"Poor prognosis of heart transplant patients with end\u2010stage renal failure","volume":"22","author":"Villar","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib24","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/j.1600-6143.2005.00852.x","article-title":"Renal histopathological lesions after orthotopic liver transplantation (OLT)","volume":"5","author":"Pillebout","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib25","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1111\/j.1600-6143.2008.02342.x","article-title":"Renal histopathological lesions after lung transplantation in patients with cystic fibrosis","volume":"8","author":"Lefaucheur","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib26","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1093\/ndt\/gfp112","article-title":"Renal biopsy in liver transplant recipients","volume":"24","author":"O\u2019Riordan","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/TP.0b013e3181c353e5","article-title":"The variable pathology of kidney disease after liver transplantation","volume":"89","author":"Kim","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib29","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1111\/j.1600-6143.2005.01043.x","article-title":"Polyoma virus nephropathy in native kidneys after lung transplantation","volume":"5","author":"Schwarz","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0272-6386(88)80001-5","article-title":"Recurrence of disease following renal transplantation","volume":"12","author":"Mathew","year":"1988","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib31","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0272-6386(12)80493-8","article-title":"Recurrent and de novo renal disease after kidney transplantation with or without cyclosporine A","volume":"17","author":"Schwarz","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib32","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/ajkd.2003.50058","article-title":"De novo thrombotic microangiopathy in renal transplant recipients: A comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy","volume":"41","author":"Schwimmer","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib33","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/00313029500169053","article-title":"Renal glomerular lesions in unselected patients with cirrhosis undergoing orthotopic liver transplantation","volume":"27","author":"Axelsen","year":"1995","journal-title":"Pathology"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib34","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1007\/s00108-003-1024-3","article-title":"Virus associated glomerulonephritis","volume":"44","author":"Tillmann","year":"2003","journal-title":"Internist (Berl)"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib35","doi-asserted-by":"crossref","first-page":"735","DOI":"10.7326\/0003-4819-144-10-200605160-00007","article-title":"Brief communication: Glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation","volume":"144","author":"McGuire","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib36","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1111\/j.1600-6143.2008.02408.x","article-title":"Chronic kidney disease after hematopoietic cell transplantation: A systematic review","volume":"8","author":"Ellis","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib37","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2215\/CJN.01781105","article-title":"Clinical outcome of thrombotic microangiopathy after living\u2010donor liver transplantation treated with plasma exchange therapy","volume":"1","author":"Nishi","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib38","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1046\/j.1523-1755.1999.00492.x","article-title":"Cyclosporine\u2010associated thrombotic microangiopathy in renal allografts","volume":"55","author":"Zarifian","year":"1999","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib39","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0041-1345(03)00614-6","article-title":"De novo hemolytic\u2010uremic syndrome\/thrombotic microangiopathy in renal transplant patients receiving calcineurin inhibitors: Role of sirolimus","volume":"35","author":"Franco","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib40","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1056\/NEJM198112033052306","article-title":"Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: Glomerular thromboses and tubular injury","volume":"305","author":"Shulman","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib41","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0140-6736(84)90842-0","article-title":"Cyclosporin\u2010induced haemolytic uraemic syndrome in liver allograft recipient","volume":"2","author":"Bonser","year":"1984","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib42","first-page":"395","article-title":"Kidney pathology in liver allograft recipients after long\u2010term treatment with cyclosporin A","volume":"58","author":"Dische","year":"1988","journal-title":"Lab Invest"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib43","first-page":"248","article-title":"Cyclosporine\u2010associated nephropathy in patients with heart and bone marrow transplants","volume":"30","author":"Nizze","year":"1988","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib44","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/qjmed\/89.10.751","article-title":"Cyclosporin nephrotoxicity in heart and lung transplant patients","volume":"89","author":"Griffiths","year":"1996","journal-title":"Qjm"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib45","first-page":"589","article-title":"Thrombotic microangiopathies. N Engl J Med","volume":"347","author":"Moake","year":"2002"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib46","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1182\/blood.V93.11.3798","article-title":"von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation\u2010associated, thrombotic thrombocytopenic purpura","volume":"93","author":"Van Der Plas","year":"1999","journal-title":"Blood"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib47","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0272-6386(89)80032-0","article-title":"Renal vascular and thrombotic effects of cyclosporine","volume":"13","author":"Remuzzi","year":"1989","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib48","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1056\/NEJM199206183262502","article-title":"Risk factors for cyclosporine\u2010induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases","volume":"326","author":"Feutren","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib49","first-page":"23","article-title":"Cyclosporin A nephropathy: Standardization of the evaluation of kidney biopsies","volume":"41","author":"Mihatsch","year":"1994","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib50","first-page":"356","article-title":"The side\u2010effects of ciclosporine\u2010A and tacrolimus","volume":"49","author":"Mihatsch","year":"1998","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib51","first-page":"181","article-title":"Thrombotic microangiopathy in renal transplant recipients treated with cyclosporin A","volume":"47","author":"Zent","year":"1997","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib52","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/00007890-200203150-00017","article-title":"De novo hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine\u2010sirolimus combination","volume":"73","author":"Langer","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib53","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1097\/00007890-200112270-00010","article-title":"Sirolimus (rapamycin) for the treatment of steroid\u2010refractory acute graft\u2010versus\u2010host disease","volume":"72","author":"Benito","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib54","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0272-6386(03)00424-4","article-title":"Sirolimus\u2010induced thrombotic microangiopathy in a renal transplant recipient","volume":"42","author":"Barone","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib55","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.ajkd.2003.07.008","article-title":"Thrombotic microangiopathy after renal transplantation in the United States","volume":"42","author":"Reynolds","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib56","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1034\/j.1600-6143.2003.00018.x","article-title":"Sirolimus may promote thrombotic microangiopathy","volume":"3","author":"Saikali","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib57","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/ndt\/gfh334","article-title":"De novo thrombotic microangiopathy following treatment with sirolimus: Report of two cases","volume":"20","author":"Crew","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib58","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1111\/j.1600-6143.2005.01047.x","article-title":"Sirolimus\u2010induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys","volume":"5","author":"Sartelet","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib59","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00007890-200101270-00019","article-title":"A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus\/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts","volume":"71","author":"MacDonald","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib60","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/ki.1996.417","article-title":"Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506","volume":"50","author":"Andoh","year":"1996","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib61","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0140-6736(99)03882-9","article-title":"Sirolimus\u2010tacrolimus combination immunosuppression","volume":"355","author":"McAlister","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib62","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1034\/j.1600-6143.2002.20507.x","article-title":"Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients","volume":"2","author":"Morales","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib63","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S1053-2498(01)00421-1","article-title":"Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairment","volume":"21","author":"Snell","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib64","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-2004-820880","article-title":"First experience with rapamycin\u2010based immunosuppression to improve kidney function after heart transplantation","volume":"52","author":"Trosch","year":"2004","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib65","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.healun.2007.01.010","article-title":"Recommendations for the use of everolimus (Certican) in heart transplantation: Results from the second German\u2010Austrian Certican Consensus Conference","volume":"26","author":"Rothenburger","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib66","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00007890-199608150-00002","article-title":"Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model","volume":"62","author":"Andoh","year":"1996","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib67","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1681\/ASN.V1251059","article-title":"Pharmacokinetic interactions augment toxicities of sirolimus\/cyclosporine combinations","volume":"12","author":"Podder","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib68","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1523-1755.2004.00498.x","article-title":"Sirolimus increases transforming growth factor\u2010beta1 expression and potentiates chronic cyclosporine nephrotoxicity","volume":"65","author":"Shihab","year":"2004","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib69","doi-asserted-by":"crossref","first-page":"37S","DOI":"10.1016\/S0041-1345(03)00353-1","article-title":"Two\u2010year results of multicenter phase III trials on the effect of the addition of sirolimus to cyclosporine\u2010based immunosuppressive regimens in renal transplantation","volume":"35 (3 Suppl)","author":"Kahan","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib70","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1600-6143.2006.01290.x","article-title":"Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1\u2010year report","volume":"6","author":"Kobashigawa","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib71","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1600-6143.2004.00428.x","article-title":"Increased risk of thrombotic microangiopathy in patients receiving a cyclosporin\u2010sirolimus combination","volume":"4","author":"Fortin","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2010.03224.x_bib72","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1034\/j.1600-6143.2003.00051.x","article-title":"Thrombotic micro\u2010angiopathy with sirolimus\u2010based immunosuppression: Potentiation of calcineurin\u2010inhibitor\u2010induced endothelial damage?","volume":"3","author":"Robson","year":"2003","journal-title":"Am J Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2010.03224.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522143108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522143108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2010.03224.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:52:01Z","timestamp":1761627121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522143108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":72,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S1600613522143108"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2010.03224.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biopsy\u2010Diagnosed Renal Disease in Patients After Transplantation of Other Organs and Tissues","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2010.03224.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}